Movement Alert｜Liquidia Technologies Rises 5.96% in Pre-Market Trading, YUTREPIA Commercialization Momentum and Academic Conference Catalyst

Market Focus06-29

On June 29, Liquidia Technologies rose 5.96% in pre-market trading, trading at $80.97/share, with turnover of approximately $51,100.

The rally is driven by continued strong commercialization momentum of the company's core product YUTREPIA combined with an upcoming academic conference catalyst. The company reported Q1 net product sales of approximately $130 million with over 4,500 unique patient prescriptions, swinging to profitability with EPS of $0.52, significantly beating the consensus estimate of $0.41. This represents a 215.56% improvement from a loss of $0.45 per share in the year-ago quarter. Multiple analysts subsequently raised their price targets following the Q1 results.

Additionally, the company announced on June 11 that it will present poster data at the PHA 2026 International Pulmonary Hypertension Conference, providing further near-term catalyst. The combination of accelerating revenue growth, profitability inflection, and scientific data disclosure continues to support bullish sentiment around the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137905538?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137905538","market":"us","top_or_hot":-1,"title":"Movement Alert｜Liquidia Technologies Rises 5.96% in Pre-Market Trading, YUTREPIA Commercialization Momentum and Academic Conference Catalyst","media":"Market Focus","content":"<p><p>On June 29, Liquidia Technologies rose 5.96% in pre-market trading, trading at $80.97/share, with turnover of approximately $51,100.</p><p>The rally is driven by continued strong commercialization momentum of the company's core product YUTREPIA combined with an upcoming academic conference catalyst. The company reported Q1 net product sales of approximately $130 million with over 4,500 unique patient prescriptions, swinging to profitability with EPS of $0.52, significantly beating the consensus estimate of $0.41. This represents a 215.56% improvement from a loss of $0.45 per share in the year-ago quarter. Multiple analysts subsequently raised their price targets following the Q1 results.</p><p>Additionally, the company announced on June 11 that it will present poster data at the PHA 2026 International Pulmonary Hypertension Conference, providing further near-term catalyst. The combination of accelerating revenue growth, profitability inflection, and scientific data disclosure continues to support bullish sentiment around the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Technologies Rises 5.96% in Pre-Market Trading, YUTREPIA Commercialization Momentum and Academic Conference Catalyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Technologies Rises 5.96% in Pre-Market Trading, YUTREPIA Commercialization Momentum and Academic Conference Catalyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 16:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, Liquidia Technologies rose 5.96% in pre-market trading, trading at $80.97/share, with turnover of approximately $51,100.</p><p>The rally is driven by continued strong commercialization momentum of the company's core product YUTREPIA combined with an upcoming academic conference catalyst. The company reported Q1 net product sales of approximately $130 million with over 4,500 unique patient prescriptions, swinging to profitability with EPS of $0.52, significantly beating the consensus estimate of $0.41. This represents a 215.56% improvement from a loss of $0.45 per share in the year-ago quarter. Multiple analysts subsequently raised their price targets following the Q1 results.</p><p>Additionally, the company announced on June 11 that it will present poster data at the PHA 2026 International Pulmonary Hypertension Conference, providing further near-term catalyst. The combination of accelerating revenue growth, profitability inflection, and scientific data disclosure continues to support bullish sentiment around the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1137905538","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137905538","pubTimestamp":1782720191,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, Liquidia Technologies rose 5.96% in pre-market trading, trading at $80.97/share, with turnover of approximately $51,100.The rally is driven by continued strong commercialization momentum...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"动向快讯|Liquidia Technologies盘前涨5.96%YUTREPIA商业化势头和学术会议催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On June 29, Liquidia Technologies rose 5.96% in pre-market trading, trading at $80.97/share, with turnover of approximately $51,100.The rally is driven by continued strong commercialization momentum of the company's core product YUTREPIA combined with an upcoming academic conference catalyst. The company reported Q1 net product sales of approximately $130 million with over 4,500 unique patient prescriptions, swinging to profitability with EPS of $0.52, significantly beating the consensus estimate of $0.41. This represents a 215.56% improvement from a loss of $0.45 per share in the year-ago quarter. Multiple analysts subsequently raised their price targets following the Q1 results.Additionally, the company announced on June 11 that it will present poster data at the PHA 2026 International Pulmonary Hypertension Conference, providing further near-term catalyst. The combination of accelerating revenue growth, profitability inflection, and scientific data disclosure continues to support bullish sentiment around the stock.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137905538","isCrawlerRequest":true}